Werkgroep Cardiologische centra Nederland English

GEMINI (Klaar)

A Randomized, Double-blind, Double-dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects with Acute Coronary Syndrome - GEMINI ACS 1

Middel
rivaroxaban
Populatie
acuut coronair syndroom
Fase
II
Jaar aanvang
2014
Meer informatie
ClinicalTrials.gov

GEMINI: Nieuws